Tempus AI Inc (HAM:F3M)
€ 40.4 +0.57 (+1.44%) Market Cap: 7.31 Bil Enterprise Value: 7.85 Bil PE Ratio: 0 PB Ratio: 18.91 GF Score: 41/100

Tempus AI Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 09:30PM GMT
Casey Woodring
JPMorgan Chase & Co - Analyst

All right, great. Welcome, everybody. I'm Casey Woodring from the Life Science Tools and Diagnostics Team here at JPMorgan. Welcome to our conference.

Pleased to be joined by Tempus AI's CEO, Eric Lefkofsky. We'll go through the corporate presentation, then leave time for the Q&A afterwards.

Eric, all yours.

Eric Lefkofsky
Tempus AI Inc - Founder, Chief Executive Officer

Thank you. Welcome. I don't know if there's seats up here, there's people in the back, but all means, feel free to walk up.

So I'll try to give you a little context of what we've been building at Tempus and a little bit about where we're at now.

So 10 years ago, we started Tempus to solve a single problem. Could AI-enabled diagnostics unlock precision medicine? Essentially, could we use diagnostics as a vehicle to make precision medicine as opposed to targeted medicine a reality.

In order to do so, you really need two things. You need access to vast amounts of proprietary data to train

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot